Hla-D Antigen Frequencies in Sjögren's Syndrome: Differences between the primary and secondary form

References

• Balint G., Ei-Ghobarey A., Capell H., Madkour M., CarsonDick W., Ferguson M. M., Anwar-ul-Haq M. Sjögren's syndrome: a contraindication to levamisole treatment. Brit Med J 1977; ii: 1386
   Google Scholar
• Bertram U. Xerostomia. Clinical aspects, pathology and pathogenesis. Acta Odont Scand 1967; 25: 1, (suppl. 29)
   Google Scholar
• Chused T. M., Kassan S. S., Opelz G., Mout-Sopoulos H. M., Terasaki P. I. Sjögren's syndrome associated with HLA-Dw3. N Engl J Med 1977; 296: 895
   PubMed Web of Science ®Google Scholar
• Dossetor J. B., Sargent A. V., Ivaskova E., Bodmer W. F., Stastny P. Rheumatoid arthritis. Histocompatibility Testing. Munksgaard, Copenhagen 1978; 218–219
   Google Scholar
• Frost-Larsen K., Isager H., Manthorpe R., Prause J. U. Sjögren's syndrome, a review. Ann Ophthal 1980; 12: 836
   Google Scholar
• Hinzova E., Ivanyi D., Sula K., Horejs J., Dostal C., Drizhal I. HLA-Dw3 in Sjögren's syndrome. Tissue Antigens 1977; 9: 8
   PubMedGoogle Scholar
• Ilonen J., Herva E., Tiilikainen A., Åkerblom H. K., Koivukangas T., Kouvalainen K. HLA-Dw2 as a marker of resistance against juvenile diabetes mellitus. Tissue Antigens 1978; 11: 144
   PubMedGoogle Scholar
• Kassan S. S., Gardy M. Sjögren's syndrome. An update and overview. Amer J Med 1978; 64: 1037
   PubMed Web of Science ®Google Scholar
• Kissmeyer-Nielsen F., Kjerbye K. E. Lym-phocytotoxic microtechnique. Purification of lymphocytes by flotation. Histocompatibility Testing. Munksgaard, Copenhagen 1967; 381–383
   Google Scholar
• McDevitt H. O., Tyan M. L. Genetic control of the antibody response in inbred mice. J Exp Med 1968; 128: 1
   PubMed Web of Science ®Google Scholar
• McDevitt H. O., Benacerraf B. Genetic control of specific immune responses. Advanced Immunol 1969; 11: 31
   PubMedGoogle Scholar
• McMichael A. J., Sasazuki T., McDevitt H. O., Payne R. O. Increased frequency of HLA-Cw3 and HLA-Dw4 in rheumatoid arthritis. Arthr Rheum 1977; 20: 1037
   PubMed Web of Science ®Google Scholar
• Morling N., Hellesen C, Jakobsen B. K., Platz P., Ryder L. P., Svejgaard A., Thomsen M. HLA-D, -DR and primed lymphocyte typing (PLT) defined DP-antigens in juvenile chronic arthritis. Tissue Antigens 1980, (submitted)
   Google Scholar
• Moutsopoulos H. M., Mann D. L., Johnson A. H., Chused T. M. Genetic differences between primary and secondary sicca syndrome. N Engl J Med 1979; 301: 761
   PubMed Web of Science ®Google Scholar
• Panayi G. S., Wooley P., Batchelor J. R. Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs. Br Med J 1978; ii: 1326
   Google Scholar
• Panayi G. S. Genetic predisposition to gold-and penicillamine-induced drug toxicity. Scand J Rheumatol (suppl. 33): abstract 19. Also in N Engl J Med 1980; 303: 300
   PubMedGoogle Scholar
• Platz P., Jakobsen B., Dickmeiss E., Ryder L. P., Thomsen M., Svejgaard A., Nerup J., Fog T. la and HLA-D typing of patients with multiple sclerosis (MS) and insulin dependent diabetes (IDD). Tissue Antigens 1977; 10: 192
   Google Scholar
• Ropes M. W., Bennett G. A., Cobb S., Jacox R., Jessar R. A. 1958 revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 1958; 9: 175
   PubMedGoogle Scholar
• Ryder L. P., Thomsen M., Platz P., Svejgaard A. Data reduction in LD-typing. Histocompatibility Testing. Munksgaard, Copenhagen 1975; 557–562
   Google Scholar
• Ryder L. P., Svejgaard A. Histocompatibility associated diseases. B and T cells in immune recognition, F. Loor, G. E. Roelants. Wiley, New York 1977; 437–456, Chapter 19
   Google Scholar
• Sjögren H. Zur Kenntnis der Keratoconjunctivitis sicca (Keratitis filiformis bei Hypofunktion der Tränendriisen). Acta Ophthal 1933; 11: 1, (Suppl. 2)
   Google Scholar
• Stastny P. Mixed lymphocyte cultures in rheumatoid arthritis. J Clin Invest 1976; 57: 1148
   PubMed Web of Science ®Google Scholar
• Stastny P. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med 1978; 298: 869
   PubMed Web of Science ®Google Scholar
• Svejgaard A., Platz P., Ryder L. P. Associations between HLA and some non-rheumatic diseases and possible explanations. Immunogenetics and Rheumatic Disease. Clinics in Rheumatic Diseases, D. Brewerton, 1977; 3: 239
   Google Scholar
• Talal N. H., Bunim J. J. The development of malignant lymphoma in the course of Sjögren's syndrome. Amer J Med 1964; 36: 529
   PubMed Web of Science ®Google Scholar
• Thomsen M., Hansen G. S., Svejgaard A., Jersild G., Hansen J. A., Good R. A., Dupont B. Mixed lymphocyte culture technique. Tissue Antigens 1974; 4: 495
   Web of Science ®Google Scholar
• Thomsen M., Jakobsen B., Platz P., Ryder L. P., StaubNielsen L., Svejgaard A. LD-typing, polymorphism of MLC determinants. Histocompatibility Testing. Munksgaard, Copenhagen 1975; 509–518
   Google Scholar
• Thomsen M., Morling N., Snorrason E., Svejgaard A., Serensen S. F. HLA-Dw4 and rheumatoid arthritis. Tissue Antigens 1979; 13: 56
   PubMedGoogle Scholar
• Thomsen M., Morling N., Platz P., Ryder L. P., Svejgaard A. 1980, (in preparation)
   Google Scholar
• Thorsby E., Piazza A. (1975) Histocompatibility Testing. Joint report from the Sixth International Histocompatibility Workshop Conference. II. Typing for HLA-D (LD-1 or MLC) determinants. 1975, F. Kissmeyer-Nielsen. Munksgaard, Copenhagen, 414–458
   Google Scholar
• Williams B. O., Onge R. A., Young A., Nuki G., CarsonDick W., Whaley K. Penicillin allergy in rheumatoid arthritis. With special reference to Sjögren's syndrome Ann Rheum Dis 1969; 28: 607
   Google Scholar